KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Molina Healthcare (MOH) EBITDA Margin (2016 - 2025)

Molina Healthcare's EBITDA Margin history spans 16 years, with the latest figure at 10.06% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 1735.0% year-over-year to 10.06%; the TTM value through Dec 2025 reached 2.41%, up 131.0%, while the annual FY2025 figure was 856.52%, 85767.0% down from the prior year.
  • EBITDA Margin for Q4 2025 was 10.06% at Molina Healthcare, up from 1.19% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 11.51% in Q3 2021 and bottomed at 7.29% in Q4 2024.
  • The 5-year median for EBITDA Margin is 3.28% (2023), against an average of 3.37%.
  • The largest annual shift saw EBITDA Margin crashed -1057bps in 2024 before it skyrocketed 1735bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 2.94% in 2021, then plummeted by -50bps to 1.46% in 2022, then surged by 125bps to 3.28% in 2023, then plummeted by -322bps to 7.29% in 2024, then surged by 238bps to 10.06% in 2025.
  • Per Business Quant, the three most recent readings for MOH's EBITDA Margin are 10.06% (Q4 2025), 1.19% (Q3 2025), and 3.12% (Q2 2025).